NEW YORK, Jan. 29-Joining the small crowd of genomics firms that are on the verge of losing a spot on the trading floor, Paradigm Genetics said today that Nasdaq notified the company on Jan. 24 that it is now subject to delisting.
Registering provides access to this and other free content.
Already have an account?Login Now.
Using DNA to sketch crime victims might not be a great idea, the NYTimes says.
Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.
Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.
In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.